The day in conversation for 2026-11-10

discussion

Transcript

The discussion: Tom: I was looking at that work on the unbalanced dynamic network panel data, and what struck me is how they maintain consistency for the asymptotic covariance matrix even when you have those time fixed effects layered onto spillovers. Jane: Consistency is one thing, but I’m curious about the assumptions underpinning that consistency when the network structure itself becomes highly heterogeneous across different time periods—does that still hold up under extreme variance in adjacency matrices? Lu: From my perspective on dynamic models, the complexity of handling those fixed effects often pushes us toward GMM approaches where we have to explicitly manage correlation structures; are they relying on a specific form of conditional independence assumption there, or is the estimator robust to that structural misspecification? Meng: That brings up something related to the computational side. If we’re dealing with these large network panels, generating those covariance matrices efficiently must be a huge bottleneck compared to standard assumptions, especially when we introduce dynamic elements. How does that specific QMLE method handle the dimensionality growth inherent in expanding the panel structure? Lalam: I'm more interested in where this fits with the other work. When we look at assessing treatment effect heterogeneity using those subgroup plots—the one from /papers/2602.06910—it seems like a different kind of complexity, less about the estimation method itself and more about efficiently mapping that uncertainty back onto interpretable regions. Jane: Exactly. While Tom is focused on the precision of the parameter estimates under dynamic conditions, we need to know if those homogeneity regions are stable across different levels of subgroup overlap in those clinical trials; what’s the metric they use to define "efficient" in that context?

More episodes

← Home